Claudia Palena

7.8k citations

94 papers · 6.0k indexed · h-index 43

Oncology top 0.5%
Immunology top 0.5%
Molecular Biology top 5%
Pulmonary and Respiratory Medicine top 2%
Cancer Research top 5%

Co-authors: Jeffrey Schlom Duane H. Hamilton Romaine I. Fernando Justin M. David Charli Dominguez Mary Litzinger James W. Hodge Lucas A. Horn
Topics: Immunotherapy and Immune Responses (47 papers)Cancer Immunotherapy and Biomarkers (40 papers)Cancer Cells and Metastasis (33 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Journal of Clinical Investigation Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States Argentina Italy

In The Last Decade

Claudia Palena

92 papers receiving 6.0k citations

Peers

Countries citing papers authored by Claudia Palena

Since Specialization

Citations

This map shows the geographic impact of Claudia Palena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Palena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Palena more than expected).

Fields of papers citing papers by Claudia Palena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Palena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Palena. The network helps show where Claudia Palena may publish in the future.

Co-authorship network of co-authors of Claudia Palena

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Palena. A scholar is included among the top collaborators of Claudia Palena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Palena. Claudia Palena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines 2024 ·Journal for ImmunoTherapy of Cancer ·Jeffrey Schlom,Renee N. Donahue,Claudia Palena,Sofia R. Gameiro,James W. Hodge,Duane H. Hamilton,James L. Gulley	0
2	Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies 2022 ·Journal for ImmunoTherapy of Cancer ·Christine M. Minnar,Paul L. Chariou,Lucas A. Horn,Kristin C. Hicks,Claudia Palena,Jeffrey Schlom,Sofia R. Gameiro	34
3	Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) 2021 ·Journal for ImmunoTherapy of Cancer ·Marijo Bilušić,Sheri McMahon,Ravi A. Madan,Fatima Karzai,(unknown),Renee N. Donahue,Claudia Palena,Caroline Jochéms,Jennifer L. Marté,Charalampos S. Floudas,Julius Strauss,Jason M. Redman,Houssein Abdul Sater,Shahrooz Rabizadeh,Patrick Soon‐Shiong,Jeffrey Schlom,James L. Gulley	43
4	A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules 2019 ·Clinical Cancer Research ·Margaret E. Gatti‐Mays,Julius Strauss,Renee N. Donahue,Claudia Palena,Jaydira Del Rivero,Jason M. Redman,Ravi A. Madan,Jennifer L. Marté,Lisa M. Cordes,Elizabeth Lamping,(unknown),(unknown),Eva Wagner,(unknown),Christopher R. Heery,Jeffrey Schlom,James L. Gulley	45
5	Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models 2019 ·Clinical Cancer Research ·Sarah Greene,Yvette Robbins,Wojciech K. Mydlarz,(unknown),Nicole C. Schmitt,Jay Friedman,Lucas A. Horn,Claudia Palena,Jeffrey Schlom,Dean Y. Maeda,John A. Zebala,Paúl E. Clavijo,Clint Allen	217
6	Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy 2019 ·Cancer Immunology Research ·Karin L. Lee,Stephen C. Benz,Kristin C. Hicks,Andrew Nguyen,Sofia R. Gameiro,Claudia Palena,(unknown),Zhen Su,Peter Ordentlich,Lars Rohlin,(unknown),Shahrooz Rabizadeh,Patrick Soon‐Shiong,Kayvan Niazi,Jeffrey Schlom,Duane H. Hamilton	20
7	Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack 2018 ·Frontiers in Oncology ·Duane H. Hamilton,Kristen K. McCampbell,Claudia Palena	9
8	Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury 2017 ·Clinical Cancer Research ·Christopher R. Heery,Claudia Palena,Sheri McMahon,Renee N. Donahue,Lauren M. Lepone,Italia Grenga,Ulrike Dirmeier,Lisa M. Cordes,(unknown),William L. Dahut,Harpreet Singh,Ravi A. Madan,Romaine I. Fernando,Duane H. Hamilton,Jeffrey Schlom,James L. Gulley	51
9	Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer 2016 ·Clinical Cancer Research ·Duane H. Hamilton,Lesley A. Mathews Griner,Jonathan M. Keller,Xin Hu,Noel Southall,Juan Marugán,Justin M. David,Marc Ferrer,Claudia Palena	48
10	Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer 2016 ·Endocrine Related Cancer ·Duane H. Hamilton,Mario Roselli,Patrizia Ferroni,Leopoldo Costarelli,Francesco Cavaliere,(unknown),Claudia Palena,Fiorella Guadagni	27
11	Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies 2016 ·Cell Death and Disease ·Charli Dominguez,Kwong-Yok Tsang,Claudia Palena	38
12	Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process 2014 ·Cancer Research ·Andressa Ardiani,Sofia R. Gameiro,Claudia Palena,Duane H. Hamilton,Anna Kwilas,Thomas H. King,Jeffrey Schlom,James W. Hodge	29
13	WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial–Mesenchymal Transition 2014 ·Cancer Research ·Duane H. Hamilton,(unknown),Romaine I. Fernando,Kwong-Yok Tsang,Claudia Palena	70
14	Therapeutic Cancer Vaccines 2014 ·Advances in cancer research ·Jeffrey Schlom,James W. Hodge,Claudia Palena,Kwong-Yok Tsang,Caroline Jochéms,John W. Greiner,Benedetto Farsaci,Ravi A. Madan,Christopher R. Heery,James L. Gulley	68
15	An Autocrine Loop between TGF-β1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype 2013 ·Molecular Cancer Therapeutics ·Cecilia Larocca,Joseph R. Cohen,Romaine I. Fernando,(unknown),Duane H. Hamilton,Claudia Palena	53
16	Brachyury, a Driver of the Epithelial–Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer 2012 ·Clinical Cancer Research ·Mario Roselli,Romaine I. Fernando,Fiorella Guadagni,Antonella Spila,(unknown),Raffaele Palmirotta,Leopoldo Costarelli,Mary Litzinger,Duane H. Hamilton,(unknown),(unknown),(unknown),Jeffrey Schlom,Claudia Palena	102
17	IL-8 Signaling Plays a Critical Role in the Epithelial–Mesenchymal Transition of Human Carcinoma Cells 2011 ·Cancer Research ·Romaine I. Fernando,Marianne D. Castillo,Mary Litzinger,Duane H. Hamilton,Claudia Palena	319
18	New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy 2009 ·Cancer Immunology Immunotherapy ·Vittore Cereda,Diane J. Poole,Claudia Palena,Sudipto Das,Tapan K. Bera,Cinzia Remondo,James L. Gulley,Philip M. Arlen,Junko Yokokawa,Ira Pastan,Jeffrey Schlom,Kwong Y. Tsang	29
19	Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma 2008 ·Clinical Cancer Research ·James L. Gulley,Philip M. Arlen,Kwong-Yok Tsang,Junko Yokokawa,Claudia Palena,Diane J. Poole,Cinzia Remondo,Vittore Cereda,Jacquin Jones,Mary Pazdur,Jack P. Higgins,James W. Hodge,Seth M. Steinberg,Herbert L. Kotz,William L. Dahut,Jeffrey Schlom	176
20	A novel type of dimerization motif, related to leucine zippers, is present in plant homeodomain proteins 1997 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Claudia Palena,Raquel L. Chan,Daniel H. González	8

About Claudia Palena

Claudia Palena is a scholar working on Immunology, Oncology and Biotechnology, having authored 94 papers that have together received 6.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (47 papers), Cancer Immunotherapy and Biomarkers (40 papers) and Cancer Cells and Metastasis (33 papers). The work is most often cited by research in Immunology (3.1k citations), Oncology (3.5k citations) and Cancer Research (626 citations). Claudia Palena has collaborated with scholars based in United States, Argentina and Italy. Frequent co-authors include Jeffrey Schlom, Duane H. Hamilton, Romaine I. Fernando, Justin M. David, Charli Dominguez, Mary Litzinger, James W. Hodge, Lucas A. Horn, Kwong-Yok Tsang and Kristen Fousek. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact